Innovacell Biotechnologie AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Innovacell Biotechnologie AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10584
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Innovacell Biotechnologie AG (Innovacell) is a biotechnology company that focuses on the development of therapeutic products. The company offers personalized cell therapy products for the treatment of incontinence. It provides medical products such as ICES13 and ICEF15. Innovacell’s products are used in the treatment of stress urinary incontinence and faecal incontinence. The company develops ultra-sound guided injection technologies to implant the cells into the target tissues. It also provides contract development and contract manufacturing services. The company operates laboratory and productions facilities which are located in the life science center of Innsbruck, Austria. Innovacell is headquartered in Innsbruck, Austria.

Innovacell Biotechnologie AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Innovacell Biotechnologie Raises US$11 Million In Venture Financing 10
Licensing Agreements 11
Norgine Enters Into Licensing Agreement With Innovacell For ICEF15 11
Equity Offering 12
Innovacell Biotech Raises USD3.4 Million in Private Placement of Shares 12
Innovacell Biotechnologie AG – Key Competitors 13
Innovacell Biotechnologie AG – Key Employees 14
Innovacell Biotechnologie AG – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Key Facts 2
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innovacell Biotechnologie AG, Deals By Therapy Area, 2012 to YTD 2018 8
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Innovacell Biotechnologie Raises US$11 Million In Venture Financing 10
Norgine Enters Into Licensing Agreement With Innovacell For ICEF15 11
Innovacell Biotech Raises USD3.4 Million in Private Placement of Shares 12
Innovacell Biotechnologie AG, Key Competitors 13
Innovacell Biotechnologie AG, Key Employees 14

List of Figures
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innovacell Biotechnologie AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Innovacell Biotechnologie AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Berkshire Hathaway Energy Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Berkshire Hathaway Energy Company (BHE) a subsidiary of Berkshire Hathaway Inc., generates, transmits, stores, distributes, and supplies electricity; and procures, transports, distributes and sells natural gas through its subsidiaries. It generates power through diversified energy sources su …
  • Vascular Biogenics Ltd (VBLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Vascular Biogenics Ltd (VBL) is a clinical biopharmaceutical company that discovers, develops and commercializes treatments for cancer. The company’s product pipeline includes VB-111. VBL’s product VB-111 is an anti-angiogenic agent for the specific inhibition of tumor vascular growth for ca …
  • Nelnet, Inc.:企業のM&A・事業提携・投資動向
    Nelnet, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nelnet, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Filtration Group Corporation:企業の戦略的SWOT分析
    Filtration Group Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Medical Facilities Corp (DR):製薬・医療:M&Aディール及び事業提携情報
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • AB Science SA (AB):企業の財務・戦略的SWOT分析
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • Awarepoint Corp:医療機器:M&Aディール及び事業提携情報
    Summary Awarepoint Corp (Awarepoint) is a healthcare technology company that provides real time location system. The company offers technology, software and managed services. It provides location software packages for mobile phones and other electronics. Awarepoint’s software packages provide patien …
  • American Tower Corp (AMT):企業の財務・戦略的SWOT分析
    American Tower Corp (AMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ashley Furniture Industries Inc:企業の戦略・SWOT・財務分析
    Ashley Furniture Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Ashley Furniture Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Technogenetics srl-医療機器分野:企業M&A・提携分析
    Summary Technogenetics srl (Technogenetics), a subsidiary of Shanghai Kehua Bio-engineering Co Ltd, is a biotechnology company that offers reagents in the field of biotechnology and pharmacology. The company provides immunodiagnostics products in the areas of infectious disease, and autoimmunity. It …
  • Navios Maritime Acquisition Corp:企業のM&A・事業提携・投資動向
    Navios Maritime Acquisition Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navios Maritime Acquisition Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • The Central Bank of the Russian Federation:企業の戦略的SWOT分析
    The Central Bank of the Russian Federation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • China Vanke Co., Ltd.:企業の戦略・SWOT・財務情報
    China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of rare inherited diseases and cancers. The company’s lead product DCR-PHXC is used for the treatment of primary hyperoxaluria (PH). It offers RNAi technology platf …
  • Beach Energy Ltd (BPT):企業の財務・戦略的SWOT分析
    Beach Energy Ltd (BPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Marina Biotech, Inc.:企業の戦略・SWOT・財務情報
    Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ashland Global Holdings Inc (ASH):企業の財務・戦略的SWOT分析
    Ashland Global Holdings Inc (ASH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Xerox Corporation:企業の戦略・SWOT・財務情報
    Xerox Corporation - Strategy, SWOT and Corporate Finance Report Summary Xerox Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Oracle Corporation:企業の戦略・SWOT・財務情報
    Oracle Corporation - Strategy, SWOT and Corporate Finance Report Summary Oracle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Carl Zeiss AG:医療機器:M&Aディール及び事業提携情報
    Summary Carl Zeiss AG (Carl Zeiss) is a medical technology with focus on optical and optoelectronic industry. It develops and distributes lithography optics, measuring technology, photomask systems, microscopes, medical technology products including ophthalmic diagnostic and therapeutic products, ey …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆